News about supervision and inspection of pharmaceutical companies

  • Extraordinary measures for clinical trials due to COVID-19

    | 09 October 2020 |

    UPDATED. We are aware that COVID-19 has consequences with regards to the conduct of clinical trials in Denmark. Multiple factors play a role such as trial participants in quarantine, limited access to public places (including hospitals) due to the risk of spreading infections etc.